-
-
-
-
-
-
-
Krystal Biotech (KRYS) Announces FDA 3-Month Extension of BLA PDUFA Date and Regulatory Update for B-VEC
-
-
-
-
-
-
-
Krystal Biotech (KRYS) Announces FDA Accepts its Biologics License Application for Dystrophic Epidermolysis Bullosa
-
-
-
-
-
-
-
Krystal Biotech (KRYS) Announces KB103 Granted Orphan Drug Designation by FDA to Treat Patients With DEB
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

